ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug Authority (SFDA) has granted accelerated approval of ANKTIVA® (nogapendekin alfa inbakicept) ...

OpenAI has just entered into a major multi-billion partnership with Cerebras Systems, which is reportedly backed by Sam ...

For centuries, the medical community attributed gastric ulcers to lifestyle factors, particularly the consumption of ...

Industry leaders share perspectives on ageing, preventive care, cancer screening, eye health, and healthcare workforce ...

After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely ...

RELATED PHOTO GALLERY State lawmakers and stakeholders expressed myriad concerns over the proposed partnership between Hawaii ...

Doctors have expressed their concerns over the recent decision of the National Board of Examinations (NBE) to reduce the ...

Rakuten Medical's proprietary photoimmunotherapy technology is designed to selectively target cells in solid tumors, by combining cell-targeting moieties, such as antibodies, with light-activatable ...

Affidea Group, Europe's leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including ...

By year-end 2028, submit new drug application evaluating cemsidomide and dexamethasone for potential accelerated approval in fourth line or later. In Q2 2026, initiate the Phase 1b trial of ...

In this conversation, Jan DeFehr argues that ethical practice requires access to what the field itself disputes, including ...

SGS has announced the launch of the ISO/IEC 42119 series, a new set of international standards dedicated to the testing of AI systems. The first publication, ISO/IEC TS 42119-2:2025, provides an ...